Our experience with gastrointestinal stromal tumors over a period of three years from a tertiary care centre

M. Vasundhara, G. Parvathi, A. Bhagya Lakshmi


Background: Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms of the gastrointestinal tract (GIT). Stomach being the commonest site in the GIT, it can occur in the extra-intestinal areas like mesentery, retroperitoneum, omentum and prostate. Exceptionally rare in urinary bladder. Commonly present as solid tumors but cystic degeneration can occur in large tumors especially in extra intestinal regions and may be mistaken for ovarian tumors. We have studied GISTs for a period of 3 years and presenting certain rare entities we encountered. Aim of the study was to study the age and sex prevalence and relative distribution of GISTs in gastrointestinal and extra gastrointestinal (EGIST) areas in various sites, and morphological features in relation to certain rare variants.

Methods: 18 surgical resected specimens of gastrointestinal and extra gastrointestinal masses received at the department of pathology, Andhra Medical College, Visakhapatnam, were studied for a period of 3 years from July 2013 to June 2016.

Results: GISTs were found to be common in male patients with male to female ratio of 2:1. GISTs of Small bowel showed female predilection. 40% of EGISTs were of larger size and malignant.

Conclusions: Age, sex and morphological features were consistent with literature.  Small intestine showed slightly increased prevalence when compared to stomach and large intestine. Tumor size and mitotic count were predictors of outcome. EGISTs showed higher incidence in women and pelvic GISTs have to be carefully evaluated to differentiate them from ovarian tumors.


GIST, EGIST, Cystic change, Mitoses

Full Text:



Phongkitkarun S, Phaisanphrukkun C, Jatchavala J, Sirachainan E. Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinibmesylate. World J Gastroenterol. 2008;14(6):892-8.

Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1466-78.

Lau S, Tam KF, Kam CK, Lui CY, Siu CW, Lam HS, Mak KL. Imaging of gastrointestinal stromal tumour (GIST). Clin Radiol. 2004;59:487-98.

Mekni A, Chelly I, Azzouz H, Ben Ghorbel I, Bellil S, Haouet S, et al. Extragastrointestinal stromal tumor of the urinary wall bladder: case report and review of the literature. Pathologica. 2008;100:173-5.

Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002;10:81-9.

Jain P, Jha AK, Rai RR. Cystic hepatic metastasis from gastrointestinal stromal tumor prior to imatinib mimicking a liver abscess. J Gastrointestin Liver Dis. 2009;18(1):121-2.

Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol. 1999;23:82-7.

Carlomagno G, Beneduce P. A gastrointestinal stromal tumor (GIST) masquerading as an ovarian mass. World J Surg Oncol. 2004;2:15.

Miettinen M, Lasota J. Gastrointestinal stromal tumors: Definition, clinical, histological, immune-histochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438:1-12.

Goh BK, Chow PK, Kesavan SM, Yap WM, Chung YF, Wong WK. A single-institution experience with eight CD117-positive primary extragastrointestinal stromal tumors: critical appraisal and a comparison with their gastrointestinal counterparts. J Gastrointest Surg. 2009;13:1094-8.

Reith J, Goldblum JR, Weiss SW. Extragastrointestinal (soft tissue) stromal tumors: An analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000;13:577-85.

Shaikh ST, Upwanshi MH, Shetty TS, Ghetla SR, Gheewala H. A large cystic variant of gastro-intestinal stromal tumour arising from the jejunum:a case report. J Clin Diagn Res. 2015;9(4):PD11-2.